RespireRx Pharmaceuticals Inc (RSPI) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

RespireRx Pharmaceuticals Inc (RespireRx), formerly Cortex Pharmaceuticals, Inc., focuses on the discovery, development and commercialization of innovative products for the treatment of various respiratory disorders. It has two drug platforms, each with a clinical stage compound directed at breathing disorders. The companys respiratory disease product pipeline includes compounds in various development stages for the treatment of obstructive sleep apnea (OSA), chronic and post-surgical central sleep apnea (CSA), opioid induced respiratory depression, spinal cord injury, and induced respiratory depression. Its lead product, Dronabinol, an oral capsule drug product completed Phase II trials for the treatment of OSA. RespireRx is headquartered in Glen Rock, New Jersey, the US.

RespireRx Pharmaceuticals Inc (RSPI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
RespireRx Pharma Raises Funds through in Venture Financing 10
RespireRx Pharma Raises USD0.1 Million in Financing 11
Partnerships 12
RespireRx Pharma to Enter into Agreement Noramco 12
RespireRx Pharma Enters into Research Agreement with National Institute of Drug Abuse 13
Licensing Agreements 14
Cortex Pharma Enters into Licensing Agreement with University of Illinois 14
Samyang Optics Enters into Licensing Agreement with Cortex Pharma 16
Equity Offering 17
Cortex Pharma Raises USD0.7 Million in First Tranche of Private Placement of Units 17
Acquisition 18
Cortex Pharma Acquires Pier Pharma, Sleep Apnea Drug Development Company 18
RespireRx Pharmaceuticals Inc - Key Competitors 19
RespireRx Pharmaceuticals Inc - Key Employees 20
RespireRx Pharmaceuticals Inc - Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Aug 25, 2017: RespireRx Pharmaceuticals Files June 30, 2017 Quarterly Report on Form 10-Q And Provides Update 22
Product News 24
12/06/2017: Synthetic Cannabis-like Drug Reduces Sleep Apnea 24
Clinical Trials 26
Jan 08, 2018: RespireRx Pharma to Present on Dronabinol at 10th Annual Biotech Showcase 2018 26
Nov 30, 2017: RespireRx Pharmaceuticals Announces Publication of Phase 2B PACE Study: Once per Night Treatment with Dronabinol Provides Statistically Significant Improvement in Clinical Measures of Obstructive Sleep Apnea 27
Sep 08, 2017: RespireRxs CEO to Present Clinical Trial plans for Dronabinol at 2017 Rodman & Renshaw Conference 29
Feb 10, 2017: RespireRx Pharmaceuticals to Present Data on dronabinol at BIO CEO & Investor Conference 2017 30
Jan 06, 2017: RespireRx Pharmaceuticals to Present Data on Dronabinol at 9th Annual Biotech Showcase 2017 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List Of Tables

List of Tables
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
RespireRx Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
RespireRx Pharma Raises Funds through in Venture Financing 10
RespireRx Pharma Raises USD0.1 Million in Financing 11
RespireRx Pharma to Enter into Agreement Noramco 12
RespireRx Pharma Enters into Research Agreement with National Institute of Drug Abuse 13
Cortex Pharma Enters into Licensing Agreement with University of Illinois 14
Samyang Optics Enters into Licensing Agreement with Cortex Pharma 16
Cortex Pharma Raises USD0.7 Million in First Tranche of Private Placement of Units 17
Cortex Pharma Acquires Pier Pharma, Sleep Apnea Drug Development Company 18
RespireRx Pharmaceuticals Inc, Key Competitors 19
RespireRx Pharmaceuticals Inc, Key Employees 20
RespireRx Pharmaceuticals Inc, Subsidiaries 21

List Of Figures

List of Figures
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

RespireRx Pharmaceuticals Inc (RSPI) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

RespireRx Pharmaceuticals Inc (RespireRx), formerly Cortex Pharmaceuticals, Inc., focuses on the discovery, development and commercialization of innovative products for the treatment of various respiratory disorders. It has two drug platforms,

USD 250 View Report

RespireRx Pharmaceuticals Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

RespireRx Pharmaceuticals Inc Company Profile is a detailed strategic and analytical report on RespireRx Pharmaceuticals Inc. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200 View Report

EyePoint Pharmaceuticals Inc (PSDV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert

USD 250 View Report

EyePoint Pharmaceuticals Inc (PSDV) - Medical Equipment - Deals and Alliances Profile

EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available